Advertisement
Advertisement
SMTI
Sanara MedTech Inc. Common Stock
32.67
USDSponsored
-0.06
-0.18%
Nov 19, 15:59 UTC -5
Closed
After-Market
32.88
+0.21
+0.66%
Sanara MedTech Inc. Common Stock (SMTI) Earnings
SMTI Earnings Reports
Positive Surprise Ratio
SMTI beat 9 of 20 last estimates.
45%
Next Report
Date of Next Report
Mar 22, 2027
Estimate for Q4 26 (Revenue/ EPS)
$31.31M
/$0.13
Implied change from Q3 26 (Revenue/ EPS)
+10.14%
/-181.25%
Implied change from Q4 25 (Revenue/ EPS)
+13.68%
/+44.44%
Sanara MedTech Inc. Common Stock earnings per share and revenue
On Nov 12, 2026, SMTI reported earnings of -0.16 USD per share (EPS) for Q3 26, missing the estimate of 0.06 USD, resulting in a -361.44% surprise. Revenue reached 28.43 million, compared to an expected 30.26 million, with a -6.05% difference. The market reacted with a +2.34% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.13 USD, with revenue projected to reach 31.31 million USD, implying an decrease of -181.25% EPS, and increase of 10.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%

Agape ATP Corporation Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-Actual
-$0.08
Surprise
-
FAQ
What were Sanara MedTech Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Sanara MedTech Inc. Common Stock reported EPS of -$0.16, missing estimates by -361.44%, and revenue of $28.43M, -6.05% below expectations.
How did the market react to Sanara MedTech Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 2.34%, changed from $31.61 before the earnings release to $32.35 the day after.
When is Sanara MedTech Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 22, 2027.
What are the forecasts for Sanara MedTech Inc. Common Stock's next earnings report?
Based on --
analysts, Sanara MedTech Inc. Common Stock is expected to report EPS of $0.13 and revenue of $31.31M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.